Medicare Enrolled
Dr. Eric Shakespeare, M.D.
Critical Care Medicine · Allentown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shakespeare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shakespeare?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shakespeare
Dr. Eric Shakespeare is a critical care medicine specialist in Allentown, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shakespeare performed 3,338 Medicare services across 2,038 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shakespeare received a total of $7,483 from 47 pharmaceutical and/or device companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shakespeare is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 3% volume in PA
$7,483 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,338
Medicare services
Top 3% in PA for critical care medicine
2,038
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~185 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
545 | $98 | $271 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
530 | $38 | $108 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
511 | $40 | $137 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
342 | $63 | $151 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
324 | $64 | $195 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
195 | $7 | $40 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
189 | $10 | $30 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
146 | $8 | $35 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
137 | $32 | $87 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $122 | $336 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
84 | $175 | $597 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
74 | $11 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
59 | $107 | $285 |
| Inpatient or observation ventilation management Follow-up care for a patient receiving ventilator support during an inpatient stay or observation period. This service involves the ongoing management and adjustment of breathing assistance. |
21 | $52 | $139 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $98 | $216 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
17 | $55 | $262 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $44 | $121 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
12 | $88 | $260 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
11 | $34 | $419 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,483
Total received (2018-2024)
Avg $1,069/year across 7 years
Top 15% in PA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
345
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,438 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$671
2023
$2,044
2022
$1,909
2021
$641
2020
$540
2019
$725
2018
$953
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
JAZZ PHARMACEUTICALS INC.
$287
GlaxoSmithKline, LLC.
$87
Amgen Inc.
$53
Gilead Sciences, Inc.
$35
AstraZeneca Pharmaceuticals LP
$32
Takeda Pharmaceuticals U.S.A., Inc.
$32
Mallinckrodt Hospital Products Inc.
$30
HARMONY BIOSCIENCES LLC
$29
Janssen Pharmaceuticals, Inc
$27
Avadel CNS Pharmaceuticals, LLC
$21
PFIZER INC.
$20
Paratek Pharmaceuticals, Inc.
$18
Top 3 companies account for 63.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,395
AstraZeneca Pharmaceuticals LP
$1,265
Insmed, Inc.
$552
JAZZ PHARMACEUTICALS INC.
$540
Philips Electronics North America Corporation
$376
Boehringer Ingelheim Pharmaceuticals, Inc.
$313
Regeneron Healthcare Solutions, Inc.
$278
Mallinckrodt Hospital Products Inc.
$223
Harmony Biosciences LLC
$205
Takeda Pharmaceuticals U.S.A., Inc.
$194
Grifols USA, LLC
$176
Mylan Specialty L.P.
$155
Amgen Inc.
$149
Genentech USA, Inc.
$145
HARMONY BIOSCIENCES LLC
$133
PFIZER INC.
$122
Sunovion Pharmaceuticals Inc.
$109
Mallinckrodt Enterprises LLC
$92
Axsome Therapeutics, Inc.
$88
Janssen Pharmaceuticals, Inc
$75
Advanced Respiratory, Inc
$74
Resmed Corp
$68
Actelion Pharmaceuticals US, Inc.
$66
Gilead Sciences, Inc.
$52
Alexion Pharmaceuticals, Inc.
$49
Pulmonx Corporation
$44
Acerta Pharma LLC
$43
Vapotherm Inc
$41
Olympus America Inc.
$40
Electromed, Inc.
$38
Merck Sharp & Dohme LLC
$38
Circassia Pharmaceuticals Inc
$37
GENZYME CORPORATION
$37
Baxter Healthcare
$27
Inspire Medical Systems, Inc.
$25
ANI Pharmaceuticals, Inc.
$25
Jazz Pharmaceuticals Inc.
$24
Avadel CNS Pharmaceuticals, LLC
$21
BOSTON SCIENTIFIC CORPORATION
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Paratek Pharmaceuticals, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
Mallinckrodt LLC
$16
IDORSIA PHARMACEUTICALS US INC
$16
Novartis Pharmaceuticals Corporation
$14
Tactile Systems Technology Inc
$14
Shire North American Group Inc
$14
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
(147) Home Sleep Testing · (8874) inCourage · ACTHAR · AIRCURVE · AIRSUPRA · ALAIR · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GLASSIA · Hillrom - Life 2000 Ventilation System · INSPIRE · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · LifeVest · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · Respiratory Core Devices · S&RC Und · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · ULTOMIRIS · UPTRAVI · Utibron · VAPOTHERM · Veklury · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
32
Per 100K population
8.5
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shakespeare is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shakespeare experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shakespeare performed 545 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shakespeare receive payments from pharmaceutical companies?
Yes. Dr. Shakespeare received a total of $7,483 from 47 companies across 345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shakespeare's costs compare to other critical care medicines in Allentown?
Dr. Shakespeare's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shakespeare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Allentown
Browse critical care medicines in Allentown ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in PA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in PA
Which PA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology